Skip to main content
. 2021 May 28;4(5):e2111813. doi: 10.1001/jamanetworkopen.2021.11813

Table 2. Association of Marital Status With CSS, Advanced-Stage Diagnosis, and Treatment by Cancer Site and Sex.

Cancer and sex CSS Diagnosed at an advanced stage Receiving surgery Receiving chemotherapy Receiving RT
TR for marriage (95% CI)a P value OR for marriage (95% CI)b P value OR for marriage (95% CI)c P value OR for marriage (95% CI)d P value OR for marriage (95% CI)e P value
Lung
Male 1.12 (1.11-1.14) <.001 1.00 (0.98-1.03) .83 1.53 (1.47-1.59) <.001 1.06 (1.04-1.09) <.001 1.57 (1.53-1.61) <.001
Female 1.08 (1.06-1.10) <.001 1.02 (1.00-1.05) .10 1.33 (1.28-1.38) <.001 1.05 (1.02-1.08) <.001 1.32 (1.28-1.35) <.001
Colorectum
Male 1.28 (1.25-1.32) <.001 0.91 (0.80-0.94) <.001 1.52 (1.46-1.58) <.001 0.89 (0.86-0.92) <.001 1.34 (1.30-1.38) <.001
Female 1.22 (1.19-1.26) <.001 0.91 (0.89-0.94) <.001 1.20 (1.15-1.25) <.001 0.93 (0.89-0.97) <.001 1.31 (1.26-1.35) <.001
Pancreas
Male 1.16 (1.12-1.19) <.001 1.01 (0.95-1.07) .77 1.34 (1.22-1.47) <.001 1.06 (0.99-1.15) .10 1.63 (1.54-1.72) <.001
Female 1.08 (1.05-1.11) <.001 1.06 (1.00-1.11) .05 1.24 (1.14-1.35) <.001 0.99 (0.92-1.06) .71 1.50 (1.42-1.59) <.001
Bladder
Male 1.50 (1.43-1.57) <.001 0.81 (0.77-0.85) <.001 1.25 (1.12-1.39) <.001 0.76 (0.70-0.82) <.001 1.17 (1.12-1.23) <.001
Female 1.40 (1.28-1.53) <.001 0.96 (0.88-1.04) .31 1.14 (0.95-1.37) .15 0.78 (0.68-0.88) <.001 1.25 (1.15-1.36) <.001
Kidney
Male 1.18 (1.12-1.23) <.001 0.91 (0.88-0.95) <.001 1.76 (1.63-1.91) <.001 1.03 (0.94-1.14) .49 1.29 (1.20-1.38) <.001
Female 1.09 (1.02-1.16) .009 0.97 (0.92-1.03) .29 1.31 (1.18-1.45) <.001 0.95 (0.84-1.08) .45 1.17 (1.06-1.29) .001
Melanoma
Male 1.42 (1.34-1.50) <.001 0.71 (0.67-0.74) <.001 1.08 (0.99-1.19) .10 0.94 (0.85-1.05) .29 1.03 (0.92-1.15) .66
Female 1.35 (1.24-1.47) <.001 0.79 (0.74-0.84) <.001 0.97 (0.86-1.09) .61 0.91 (0.77-1.06) .21 1.13 (0.96-1.32) .14
Breast
Male 1.76 (1.19-2.61) .005 0.83 (0.69-0.99) .04 1.05 (0.53-2.03) .90 1.00 (0.73-1.37) >.99 1.09 (0.79-1.50) .59
Female 1.10 (1.07-1.14) <.001 0.80 (0.78-0.81) <.001 1.33 (1.26-1.39) <.001 1.100 (1.07-1.13) <.001 1.05 (1.03-1.07) <.001
Total sample
Male 1.27 (1.25-1.28) <.001 0.85 (0.84-0.86) <.001 1.43 (1.40-1.46) <.001 1.33 (1.31-1.35) <.001 0.91 (0.90-0.93) <.001
Female 1.20 (1.19-1.21) <.001 0.83 (0.82-0.84) <.001 1.31 (1.29-1.33) <.001 1.23 (1.22-1.25) <.001 1.16 (1.14-1.17) <.001

Abbreviations: CSS, cancer-specific survival; OR, odds ratio; RT, radiation therapy; TR, time ratio.

a

Adjusted for patient demographic characteristics (age, race, sex, insurance status, residence, poverty level, and educational level), stage, grade, receiving surgery, receiving chemotherapy, and receiving RT.

b

Adjusted for patient demographic characteristics and grade.

c

Adjusted for patient demographic characteristics, stage, grade, receiving chemotherapy, and receiving RT.

d

Adjusted for patient demographic characteristics, stage, grade, receiving surgery, and receiving RT.

e

Adjusted for patient demographic characteristics, stage, grade, receiving chemotherapy, and receiving surgery.